These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22260203)

  • 1. [1,2,4]triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazoles: antagonists of the Wnt pathway that inhibit tankyrases 1 and 2 via novel adenosine pocket binding.
    Shultz MD; Kirby CA; Stams T; Chin DN; Blank J; Charlat O; Cheng H; Cheung A; Cong F; Feng Y; Fortin PD; Hood T; Tyagi V; Xu M; Zhang B; Shao W
    J Med Chem; 2012 Feb; 55(3):1127-36. PubMed ID: 22260203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-efficiency relationship of [1,2,4]triazol-3-ylamines as novel nicotinamide isosteres that inhibit tankyrases.
    Shultz MD; Majumdar D; Chin DN; Fortin PD; Feng Y; Gould T; Kirby CA; Stams T; Waters NJ; Shao W
    J Med Chem; 2013 Sep; 56(17):7049-59. PubMed ID: 23879431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
    Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
    Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity.
    Narwal M; Koivunen J; Haikarainen T; Obaji E; Legala OE; Venkannagari H; Joensuu P; Pihlajaniemi T; Lehtiö L
    J Med Chem; 2013 Oct; 56(20):7880-9. PubMed ID: 24116873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pinworm and TNKS inhibitors, an eccentric duo to derail the oncogenic WNT pathway.
    Ouelaa-Benslama R; Emami S
    Clin Res Hepatol Gastroenterol; 2011 Sep; 35(8-9):534-8. PubMed ID: 21782548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. para-Substituted 2-phenyl-3,4-dihydroquinazolin-4-ones as potent and selective tankyrase inhibitors.
    Haikarainen T; Koivunen J; Narwal M; Venkannagari H; Obaji E; Joensuu P; Pihlajaniemi T; Lehtiö L
    ChemMedChem; 2013 Dec; 8(12):1978-85. PubMed ID: 24130191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, Dynamics, and Functionality of Tankyrase Inhibitor-Induced Degradasomes.
    Thorvaldsen TE; Pedersen NM; Wenzel EM; Schultz SW; Brech A; Liestøl K; Waaler J; Krauss S; Stenmark H
    Mol Cancer Res; 2015 Nov; 13(11):1487-501. PubMed ID: 26124443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular insights on TNKS1/TNKS2 and inhibitor-IWR1 interactions.
    Kirubakaran P; Kothandan G; Cho SJ; Muthusamy K
    Mol Biosyst; 2014 Feb; 10(2):281-93. PubMed ID: 24291818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitors.
    Hua Z; Bregman H; Buchanan JL; Chakka N; Guzman-Perez A; Gunaydin H; Huang X; Gu Y; Berry V; Liu J; Teffera Y; Huang L; Egge B; Emkey R; Mullady EL; Schneider S; Andrews PS; Acquaviva L; Dovey J; Mishra A; Newcomb J; Saffran D; Serafino R; Strathdee CA; Turci SM; Stanton M; Wilson C; Dimauro EF
    J Med Chem; 2013 Dec; 56(24):10003-15. PubMed ID: 24294969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of Wnt/β-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells.
    Kulak O; Chen H; Holohan B; Wu X; He H; Borek D; Otwinowski Z; Yamaguchi K; Garofalo LA; Ma Z; Wright W; Chen C; Shay JW; Zhang X; Lum L
    Mol Cell Biol; 2015 Jul; 35(14):2425-35. PubMed ID: 25939383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel binding mode of a potent and selective tankyrase inhibitor.
    Gunaydin H; Gu Y; Huang X
    PLoS One; 2012; 7(3):e33740. PubMed ID: 22438990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tankyrase Inhibitors Stimulate the Ability of Tankyrases to Bind Axin and Drive Assembly of β-Catenin Degradation-Competent Axin Puncta.
    Martino-Echarri E; Brocardo MG; Mills KM; Henderson BR
    PLoS One; 2016; 11(3):e0150484. PubMed ID: 26930278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors.
    Bregman H; Chakka N; Guzman-Perez A; Gunaydin H; Gu Y; Huang X; Berry V; Liu J; Teffera Y; Huang L; Egge B; Mullady EL; Schneider S; Andrews PS; Mishra A; Newcomb J; Serafino R; Strathdee CA; Turci SM; Wilson C; DiMauro EF
    J Med Chem; 2013 Jun; 56(11):4320-42. PubMed ID: 23701517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for tankyrases as antineoplastic targets in lung cancer.
    Busch AM; Johnson KC; Stan RV; Sanglikar A; Ahmed Y; Dmitrovsky E; Freemantle SJ
    BMC Cancer; 2013 Apr; 13():211. PubMed ID: 23621985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for the interaction between tankyrase-2 and a potent Wnt-signaling inhibitor.
    Karlberg T; Markova N; Johansson I; Hammarström M; Schütz P; Weigelt J; Schüler H
    J Med Chem; 2010 Jul; 53(14):5352-5. PubMed ID: 20565110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and structural analysis of adenosine site binding tankyrase inhibitors.
    Haikarainen T; Waaler J; Ignatev A; Nkizinkiko Y; Venkannagari H; Obaji E; Krauss S; Lehtiö L
    Bioorg Med Chem Lett; 2016 Jan; 26(2):328-333. PubMed ID: 26706174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP25 regulates Wnt signaling by controlling the stability of tankyrases.
    Xu D; Liu J; Fu T; Shan B; Qian L; Pan L; Yuan J
    Genes Dev; 2017 May; 31(10):1024-1035. PubMed ID: 28619731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of TNKS1 is correlated with pathologic grade and Wnt/β-catenin pathway in human astrocytomas.
    Tang B; Wang J; Fang J; Jiang B; Zhang M; Wang Y; Yang Z
    J Clin Neurosci; 2012 Jan; 19(1):139-43. PubMed ID: 22154485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tankyrase Sterile α Motif Domain Polymerization Is Required for Its Role in Wnt Signaling.
    Riccio AA; McCauley M; Langelier MF; Pascal JM
    Structure; 2016 Sep; 24(9):1573-81. PubMed ID: 27499439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of selective inhibition of human tankyrases.
    Narwal M; Venkannagari H; Lehtiö L
    J Med Chem; 2012 Feb; 55(3):1360-7. PubMed ID: 22233320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.